share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

諾瓦瓦克斯醫藥 | 4:持股變動聲明-董事 YOUNG JAMES F
美股sec公告 ·  06/14 16:06
Moomoo AI 已提取核心訊息
James F. Young, associated with Novavax Inc [NVAX], completed a transaction on 06/12/2024 involving the acquisition of 6,670 shares of common stock at no cost. This transaction was categorized as an exercise or conversion of derivative security, directly increasing Young's holdings to a total of 76,760 shares of Novavax common stock.
James F. Young, associated with Novavax Inc [NVAX], completed a transaction on 06/12/2024 involving the acquisition of 6,670 shares of common stock at no cost. This transaction was categorized as an exercise or conversion of derivative security, directly increasing Young's holdings to a total of 76,760 shares of Novavax common stock.
諾瓦瓦克斯醫藥[NVAX]相關人員詹姆斯·F·楊於2024年06月12日完成了一筆交易,免費獲得了6,670股普通股。此次交易被歸類爲衍生證券行權或轉換,直接增加了楊先生持有的諾瓦瓦克斯醫藥普通股總數至76,760股。
諾瓦瓦克斯醫藥[NVAX]相關人員詹姆斯·F·楊於2024年06月12日完成了一筆交易,免費獲得了6,670股普通股。此次交易被歸類爲衍生證券行權或轉換,直接增加了楊先生持有的諾瓦瓦克斯醫藥普通股總數至76,760股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息